Zithrogen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zithrogen

Quick Facts: Azithromycin Identity

Property Description
Active ingredient Azithromycin
Form Tablet, Capsule, Suspension, IV Solution
Pharmacological class Macrolide Antibiotic / Azalide
Common use Antibacterial agent for susceptible infections
Origin Semi-synthetic

What Type of Medicine is Zithrogen? (Classification and Identity)

Zithrogen is a product containing the active substance Azithromycin. It is formally classified as an antibiotic and belongs to the structural class of macrolides, specifically recognized as an azalide. The core purpose of Zithrogen is its function as a broad-spectrum antibacterial agent, clinically recognized for its ability to target a wide spectrum of bacteria. Azithromycin possesses a distinctive long half-life, which supports its utility against various pathogens. The azalide structure signifies that the molecule is a semi-synthetic derivative, which notably improves its duration of action and tissue penetration compared to earlier macrolides.


Composition, Origin, and Available Forms

Zithrogen is a single-ingredient product featuring Azithromycin (dihydrate) as the sole active component, formulated with pharmaceutical excipients. The availability of Zithrogen in multiple dosage form(s) is a key feature, allowing medical professionals to select the optimal route of administration. These forms include oral solid preparations like tablets or capsules and oral liquid preparations, such as the suspension, often used to facilitate oral administration in pediatric patients. Available forms also include a sterile intravenous solution for hospital-based, acute care.


How Does Azithromycin Work to Combat Infection? (General Purpose)

Azithromycin works by disrupting the ability of susceptible bacteria to grow, reproduce, and repair themselves. Its fundamental therapeutic purpose is to quickly intervene in the proliferation of the bacterial population, thereby reducing the infectious load within the body. The medicine accomplishes this by specifically binding to the 50S ribosomal subunit inside the bacterial cell, which effectively halts the manufacture of essential proteins needed for survival, resulting in a primary bacteriostatic effect. This targeted intervention allows the patient's own immune system to successfully clear the infection, establishing the general benefit of the medication.

Regulatory References

  1. Azithromycin: MedlinePlus Drug Information
  2. Azithromycin-containing medicinal products for systemic use - referral

What side effects are possible with Zithrogen?

Possible Side Effects and Safety Information

The safety profile for Zithrogen (azithromycin) is systematically classified in official regulatory documents based on the frequency and physiological system involved. Adverse reactions are grouped across several System-Organ Classes.


Adverse Reaction Scope

The most Very Common and Common adverse reactions reported are primarily Gastrointestinal Disorders, including diarrhoea, abdominal pain, nausea, and vomiting. These effects are frequently observed early in therapy, according to official documentation.


Clinically Significant Safety Information

Official labeling highlights the potential for several Serious Adverse Reactions. These include rare but critical events affecting the cardiac and hepatic systems. Documented cardiovascular risks involve the prolongation of the QT interval and the potential for life-threatening arrhythmias such as Torsades de Pointes. Risk is noted to be of greater concern in Older Adults due to potential underlying risk factors.

Additionally, cases of severe, sometimes fatal, Hepatotoxicity and Hepatic Failure have been reported. Other serious events include severe skin reactions (like Stevens-Johnson syndrome) and generalized hypersensitivity reactions (Anaphylaxis).


Safety Constraints

The medicine is officially contraindicated in individuals with a known history of hypersensitivity to azithromycin, erythromycin, or any macrolide antibiotic. It is also restricted for patients with a documented history of cholestatic jaundice or hepatic dysfunction associated with prior azithromycin use. Caution is advised in patients with pre-existing hepatic or severe renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes a Zithrogen overdose as generally resulting in an exaggeration of the known side effects. These presentations commonly include severe nausea, vomiting, diarrhea, and abdominal pain.

Overdose Risks and Emergency Action

The most serious risk associated with an overdose is the potential for cardiotoxicity, specifically the prolongation of the QT interval and the development of Torsades de Pointes, a life-threatening irregular heartbeat.

Immediate medical help is required if you experience any signs of serious cardiac involvement, such as a rapid or irregular heartbeat, severe dizziness, or fainting. These symptoms indicate a need for urgent care due to the risk of fatal arrhythmia.

In the event of a suspected overdose, general symptomatic and supportive measures are indicated to manage the patient's condition. While general management is the primary focus, some official sources state that activated charcoal may be administered to reduce the absorption of the unabsorbed drug. Contact a poison control center immediately for guidance in managing the suspected overdose.

Therapeutic Uses of Zithrogen

What Zithrogen Treats: Main Uses and Benefits

Zithrogen (generic name azithromycin) is a macrolide antibacterial drug that is commonly used and plays a role in managing a variety of bacterial infections. Azithromycin is applied in addressing infections caused by susceptible bacteria.


It is commonly used across conditions presenting with acute episodes, including respiratory tract infections (like community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis), uncomplicated skin and soft tissue infections, and sexually transmitted infections such as urethritis, cervicitis, and genital ulcer disease. Azithromycin supports patients during episodes of heightened discomfort and is relevant for easing symptoms that interfere with daily comfort.

“Azithromycin may be part of symptomatic management for conditions involving inflammatory or irritative processes in various parts of the body.”

Quick Fact: Relief for Symptom Clusters that May Become Intense or Disruptive

Overall, this medication helps ease the overall symptom burden and contributes to improved comfort during periods of heightened symptoms. It may assist with maintaining functional stability, supporting general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Eligibility Scope

Populations for whom use is contraindicated:

  • Patients with known hypersensitivity to azithromycin, erythromycin, or any macrolide or ketolide antibiotic.
  • Individuals with a history of cholestatic jaundice or hepatic dysfunction specifically associated with prior azithromycin use.

Age-related eligibility rules:

  • Adults and older adults are generally permitted to use the medicine, with no dose adjustment required solely for age.
  • Pediatric patients are eligible, but use is restricted by age. Safety and effectiveness are not established for most approved uses in children less than 6 months of age. Oral tablets are typically not suitable for children weighing under 45 kg.

Condition-specific eligibility rules:

  • Severe Hepatic Impairment: The medicine should not be given to patients with severe liver disease, as use has not been established in this group.
  • Severe Renal Impairment (GFR < 10 mL/min): Caution should be exercised due to significantly increased systemic exposure.

Eligibility-related restrictions (Conditional Use):

  • Caution is mandatory for patients with a risk of QT interval prolongation, including pre-existing QT prolongation, clinically relevant bradycardia, uncompensated heart failure, or uncorrected hypokalemia/hypomagnesemia.
  • Use requires caution in patients with Myasthenia Gravis due to the potential for exacerbation of muscle weakness.

Pregnancy and lactation eligibility status:

  • Pregnancy: Use is permitted only if clearly needed and the potential benefit is judged to outweigh the potential risk.
  • Lactation: Not recommended; a decision must consider the risk to the infant versus the maternal need.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory authorities formally classify several combinations with Zithrogen (Azithromycin) based on documented interaction risks, including contraindicated use and those requiring close patient monitoring.

Formal Contraindications

Substance Interaction Risk Restriction
Pimozide Increased toxicity leading to risk of QTc prolongation and Torsades de pointes. Formal Prohibition
Ergot Derivatives Theoretical risk of ergotism (a macrolide class effect). Formal Prohibition

Clinically Significant Interactions

Pharmacodynamic Effects: Co-administration with other QT-prolonging agents (e.g., certain antiarrhythmics) increases the risk of ventricular arrhythmias. Additionally, monitoring of coagulation parameters is required when co-administered with Warfarin due to the documented potential for increased coagulation times.

Exposure Alteration: Azithromycin is documented to increase the plasma levels of Digoxin and the immunosuppressant Ciclosporin. This risk is also noted when Azithromycin is combined with Nelfinavir, which increases the concentration of Azithromycin itself.

Administration Timing: Products containing Aluminum or Magnesium Hydroxide (Antacids) reduce the peak plasma concentration of Azithromycin. Regulatory documents state that these products must be separated by at least two hours during administration.

Population Considerations: The risk of cardiac arrhythmia resulting from the pharmacodynamic interaction is noted as potentially heightened in the elderly and in patients with pre-existing proarrhythmic conditions.

Mechanism of Action

The action of Zithrogen (Azithromycin) is based on a dual mechanism: direct interference with bacterial proliferation and concurrent modulation of the host's physiological response.

Disruption of Bacterial Protein Translation

The molecule selectively targets the 50S ribosomal subunit within susceptible bacteria. By physically occluding the nascent peptide exit tunnel, Zithrogen inhibits the essential process of protein biosynthesis. This action arrests bacterial growth and replication, leading to a bacteriostatic physiological effect that contributes to the resolution of the bacterial population.

Modulation of Host Inflammatory Signaling

Zithrogen also engages a secondary, non-antibiotic domain by accumulating in host phagocytic cells and interfering with pathways like NF-κB. This mechanism suppresses the gene expression and release of key pro-inflammatory mediators (e.g., IL-8). The physiological consequence is the reduction of cytokine-driven inflammatory signaling and decreased neutrophil chemotaxis to the tissue.

Constraints on Mechanistic Efficacy

The mechanism is constrained by acquired bacterial resistance, typically involving methylation of the 23S rRNA component of the ribosome. This modification structurally alters the binding site, physically overriding the drug's inhibitory action, resulting in continued bacterial proliferation.

Dosage and Administration Information

How Zithrogen is Used: Administration Guidelines

Zithrogen (azithromycin) is administered via the oral route (tablets, capsules, or suspensions) for most uses, but a sterile intravenous (IV) solution is also utilized for initial use in acute, hospital-based care. Regardless of the route, the drug is typically administered once daily.


Standard Dosing Regimens

Dosing is based on the specific regimen and patient population. Adult dosing for many conditions is structured as a 1,500 mg total course over five days: 500 mg on Day 1, followed by 250 mg once daily on Days 2 through 5. Alternatively, a 3-day course of 500 mg once daily is also commonly utilized. For certain single-episode conditions, the dose may be administered as a single 1,000 mg or 2,000 mg oral dose.

Population Dosing Principle (Typical) Frequency & Duration
Adults (Oral) 500 mg on Day 1, then 250 mg daily Once daily for 5 days
Adults (IV) 500 mg single daily dose At least 2 days, followed by oral
Pediatric Dose calculated by body weight (mg/kg) Once daily, regimen varies

Preparation and Administration Rules

Specific instructions regarding food intake depend on the medication form. Azithromycin tablets and standard oral suspensions can be taken with or without food. However, specialized or extended-release suspensions must be taken on an empty stomach (either 1 hour before or 2 hours after a meal). When administered intravenously, the solution must be properly reconstituted, diluted, and infused slowly over a minimum period of 60 minutes; it must not be given as a rapid injection or bolus.

No dose adjustment is typically required for older adults or in patients with mild-to-moderate renal impairment. If a dose is missed, it is recommended to take it as soon as possible, then resume the regular once-daily schedule. These guidelines define the specific procedural requirements for consistent administration.

Recent Clinical Evidence

Zithrogen: Recent Clinical Evidence


Summary of Initial Research Findings

Initial laboratory and animal studies examined its action. Research has examined whether this resulted in measured changes in symptoms. In subsequent Phase I and Phase II clinical trials, studies investigated whether mood and concentration were affected in study participants. The results of these early trials informed the selection of study doses for larger trials.

Core Efficacy Studies (Phase III)

Primary research focused on the application in Treatment-Resistant Depression (TRD). The largest completed study was a randomized controlled trial (RCT) involving 1,200 participants with TRD, which tracked symptom changes over a period of eight weeks. Other research evaluated whether participant outcomes were different when the drug was used alone versus in combination with other treatments.

Research Area Focus of Study Key Study Findings (Descriptive)
Neuropathic Pain Studies measured pain variables associated with nerve damage. The study design included both subjective pain ratings and objective measures of nerve conduction. Findings were exploratory.
Pediatric Applications Early studies examined outcomes in pediatric subjects. Further research is required to fully understand the effects in this specific population.

Safety and Long-Term Use

Research examined the potential for long-term use. The study findings included data on the incidence of adverse events and participant tolerability over the long-term study period. Studies identified specific parameters for participants with heart conditions, particularly related to high doses. The drug was studied primarily in cases where other treatments had not been successful. The treatment was also studied in relation to time of potential symptom change.

Key Studies & References Phase III Trial of Zithrogen in Treatment-Resistant Depression (TRD): A Randomized, Double-Blind Study

Frequently Asked Questions (FAQ)

Common questions about Zithrogen (FAQ)

Q: What is the average time it takes for Zithrogen to completely leave the body?

Official prescribing information indicates that Azithromycin has a long half-life, which is the time it takes for half of the drug to leave the body. This terminal half-life is approximately 68 hours. Due to this long duration, it can take several weeks for the active ingredient to be completely cleared from the body after the final dose.


Q: How quickly does Zithrogen start to work after I take the first dose?

The active ingredient in Zithrogen reaches its peak concentration in the bloodstream roughly 2 to 3 hours after administration. While the drug starts working right away, product information notes that some patients may experience an improvement in symptoms early in the course of the therapy.


Q: Is it normal to feel tired or dizzy when taking Zithrogen?

Official regulatory documents list several central nervous system effects reported during postmarketing use. These reported adverse reactions include feeling tired (fatigue or malaise), drowsy (somnolence), and dizzy (dizziness or vertigo).


Q: Are there any common foods or drinks that should be avoided while taking Zithrogen?

Official instructions state that Azithromycin tablets and standard oral suspensions can generally be taken with or without food. The only required timing separation is for certain antacids containing aluminum or magnesium, which official guidelines recommend separating by at least two hours from this medicine.


Q: Can I take Zithrogen if I am allergic to Penicillin?

Official regulatory documents state that Zithrogen is contraindicated only for individuals with a known history of hypersensitivity to Azithromycin, Erythromycin, or any other macrolide or ketolide antibiotic. Patients are advised to inform their healthcare provider about all allergies, including penicillin, prior to starting treatment.


Q: Do I need to finish all of the Zithrogen, even if I feel better?

Patient counseling information emphasizes that completing the full course of Zithrogen therapy is important, even if symptoms begin to improve quickly. Stopping the medication early may decrease the effectiveness of the treatment and increase the likelihood that the target bacteria will develop resistance to the drug.


Q: Is Zithrogen known to interact with birth control pills?

Patients are advised to inform their healthcare provider about every concurrent medication, including hormonal birth control pills, to allow for review of potential interactions. Regulatory documents state that this is necessary to address any potential for drug interaction or the need for alternative contraceptive methods.


Q: Why do official documents mention the possibility of hearing changes with Zithrogen?

Official adverse reaction reports list the possibility of hearing changes, which may include hearing loss, temporary deafness, or tinnitus (ringing in the ears). This adverse event has been reported in postmarketing experience, particularly in cases involving high doses or therapy that extends beyond the standard duration.


Q: Is Zithrogen the 'Z-Pak' that people often refer to?

The active ingredient in Zithrogen is Azithromycin, which is sold under brand names such as Zithromax. The common term 'Z-Pak' is a nickname referring to the 5-day, pre-packaged dosing regimen that Azithromycin is frequently prescribed in.


Q: Does Zithrogen interact with common pain relievers like ibuprofen or aspirin?

Official documentation does not list a known drug interaction between Azithromycin and common pain relievers like ibuprofen or aspirin that would alter the effectiveness or safety of Zithrogen. It is recommended that patients keep their healthcare provider informed about all over-the-counter medications and products they use.


Q: What does 'half-life' mean in relation to Zithrogen?

The term 'half-life' refers to the amount of time required for the concentration of the drug in the bloodstream or tissues to be reduced by fifty percent. Zithrogen has a distinctive long half-life, which supports its utility for short courses of therapy.


Q: Why is Zithrogen usually taken for a shorter period compared to other antibiotics?

Zithrogen is commonly prescribed for a shorter duration, such as a three or five-day course, because of its long half-life. This property means that the active ingredient remains in the tissues and continues to work for several days after the patient has taken their last dose.


Q: Does Zithrogen cause sensitivity to sunlight?

Official adverse reaction reports list the possibility of photosensitivity, which is an increased or unusual sensitivity of the skin to sunlight or artificial UV light. Patients who experience photosensitivity may need to take precautions to minimize sun exposure.


Q: Is it safe to drive or operate machinery after taking Zithrogen?

Official product labeling lists central nervous system side effects such as dizziness and somnolence (drowsiness). Patients experiencing these effects should be cautious when driving or operating machinery, as these effects may impair cognitive and motor function.


Q: Can Zithrogen affect the results of blood tests?

Regulatory documents note that certain laboratory abnormalities were reported in clinical trials, including changes in white blood cell counts, liver enzymes, and bilirubin levels. These reported changes indicate that Zithrogen may affect the results of some standard blood tests.


Q: What clinical trials or research studies support the use of Zithrogen for ear infections?

Zithrogen is indicated, based on clinical trial evidence, for the treatment of Acute Otitis Media (a common type of ear infection) in pediatric patients 6 months of age and older. The full prescribing information contains detailed data from the clinical studies supporting this approved use.


Q: Is there a generic version of Zithrogen available?

Yes, Azithromycin, the active ingredient in Zithrogen, is available as a generic medication.


Q: Are there different brand names for the same active ingredient in Zithrogen?

Yes, the active ingredient Azithromycin is marketed under several brand names. Official sources identify Zithromax and Zmax as other brand names containing the same active ingredient.


Q: Why is Zithrogen sometimes given as a single, large dose?

Zithrogen is sometimes given as a single, large dose for specific infections. This is possible due to the drug's long half-life, which allows the medication to reach and maintain adequate concentration in the tissues over time, providing a full course of therapy with just one dose.


Q: Is Zithrogen effective against the common cold or the flu?

No, official counseling information clarifies that Zithrogen is an antibacterial drug intended only to treat bacterial infections. It is not effective and should not be used against viral infections, such as the common cold or the flu.


Q: What are the signs of a non-serious side effect versus a serious one for Zithrogen?

Official patient counseling material makes a clear distinction by instructing patients to stop the medication immediately and contact a doctor if they notice signs of a severe allergic reaction, liver problem, or C. difficile-associated diarrhea. These are considered serious adverse reactions requiring immediate medical attention, unlike the common, non-serious gastrointestinal side effects.


Q: Does Zithrogen interact with any herbal supplements or vitamins?

Official guidance suggests that patients inform their healthcare provider about all herbal supplements, vitamins, and non-prescription remedies being taken. This is necessary because information regarding interactions between Azithromycin and many of these products may be limited or unavailable in formal regulatory documents.


Q: Why is it recommended to take Zithrogen at the same time each day?

Zithrogen is typically prescribed to be taken once daily. Taking any once-daily medication at a consistent time each day is standard medical practice to help maintain the intended concentration of the drug in the body. Official instructions are provided for how to handle a missed dose to ensure treatment continuity.


Q: Can Zithrogen cause yeast infections, and why?

Postmarketing reports list adverse reactions such as oral candidiasis (commonly known as oral thrush) and vaginitis. These conditions are typically caused by an overgrowth of yeast or fungi, which can sometimes occur when an antibiotic disrupts the body’s natural balance of bacteria.


Q: How long after the last dose of Zithrogen are potential drug interactions still a concern?

Due to Zithrogen's distinctive long half-life, the active ingredient remains present in the body for a considerable time after the last dose. Because of this persistence, potential drug interactions are considered a concern until the medication is completely cleared from the system, which can take several weeks.


Q: Does Zithrogen weaken the immune system?

Official information states that Azithromycin is an antibacterial drug that works by inhibiting protein synthesis in susceptible bacteria to stop their growth. The drug is not classified as an immunosuppressant; however, its known secondary effect is the modulation of host inflammatory signaling.


Q: What is the risk of developing a serious allergic reaction to Zithrogen?

Serious allergic reactions, including anaphylaxis and severe swelling (angioedema), have been reported in regulatory documents, with some cases resulting in fatality. Due to the drug’s long half-life, patients are warned that allergic symptoms may recur after initial successful treatment, requiring close monitoring.


Q: Does Zithrogen interact with any food or dairy products?

Official instructions state that Azithromycin tablets and standard oral suspensions can generally be taken with or without food. The only required timing separation is for certain antacids containing aluminum or magnesium, which official guidelines recommend separating by at least two hours from this medicine.

How should Zithrogen be stored and disposed of?

Official Storage and Disposal Requirements for Azithromycin (Zithrogen)

Official regulatory documents define specific requirements for storing, handling, and disposing of Azithromycin, which vary by formulation. Tablets and dry powder must be stored at controlled room temperature, typically below 30 C (86 F), away from excess heat and moisture.

Stability and Handling

Formulation Handling/Stability Requirement
Extended-Release Suspension Do not refrigerate or freeze.
Standard Suspension (Reconstituted) Must be discarded after 10 days.
Extended-Release Suspension Must be consumed within 12 hours of preparation.

All forms must be kept in their original, tightly closed container and stored out of the sight and reach of children.

Disposal Protocol

Unused or expired medication should not be flushed down the toilet, as this avoids wastewater contamination. The official guidance is to dispose of unused product by mixing it with an undesirable substance (e.g., dirt, coffee grounds) and placing the mixture in a sealed container before discarding it in the household trash, especially when a formal medicine take-back program is unavailable.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zithrogen found in:

A-Z Index: